George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMc Mining Regulatory News (MCM)

Share Price Information for Mc Mining (MCM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 8.00
Bid: 7.50
Ask: 8.50
Change: 0.00 (0.00%)
Spread: 1.00 (13.333%)
Open: 8.00
High: 8.00
Low: 8.00
Prev. Close: 8.00
MCM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appendix 5B

30 Oct 2020 07:00

RNS Number : 6832D
MC Mining Limited
30 October 2020
 

Appendix 5B

Mining exploration entity or oil and gas exploration entityquarterly cash flow report

Name of entity

MC Mining Limited

ABN

 

Quarter ended ("current quarter")

98 008 905 388

30 September 2020

 

Consolidated statement of cash flows

Current quarterUSD'000

Year to date (three months)USD'000

1.

Cash flows from operating activities

3,973

3,973

1.1

Receipts from customers

1.2

Payments for

(a) exploration & evaluation

(b) development

(c) production

(3,974)

(3,974)

(d) staff costs

(430)

(430)

(e) administration and corporate costs

(801)

(801)

1.3

Dividends received (see note 3)

1.4

Interest received

-

-

1.5

Interest and other costs of finance paid

(12)

(12)

1.6

Income taxes paid

1.7

Government grants and tax incentives

1.8

Other (provide details if material)

10

10

1.9

Net cash from / (used in) operating activities

(1,234)

(1,234)

2.

Cash flows from investing activities

2.1

Payments to acquire or for:

(a) entities

(b) tenements

(c) property, plant and equipment

(39)

(39)

(d) exploration & evaluation

(10)

(10)

(e) investments

(104)

(104)

(f) other non-current assets

2.2

Proceeds from the disposal of:

(a) entities

(b) tenements

(c) property, plant and equipment

510

510

(d) investments

(e) other non-current assets

2.3

Cash flows from loans to other entities

2.4

Dividends received (see note 3)

2.5

Other (provide details if material)

(62)

(62)

2.6

Net cash from / (used in) investing activities

295

295

3.

Cash flows from financing activities

885

885

3.1

Proceeds from issues of equity securities (excluding convertible debt securities)

3.2

Proceeds from issue of convertible debt securities

3.3

Proceeds from exercise of options

3.4

Transaction costs related to issues of equity securities or convertible debt securities

3.5

Proceeds from borrowings

1,462

1,462

3.6

Repayment of borrowings

(113)

(113)

3.7

Transaction costs related to loans and borrowings

3.8

Dividends paid

3.9

Other (provide details if material)

(217)

(217)

3.10

Net cash from / (used in) financing activities

2,017

2,017

4.

Net increase / (decrease) in cash and cash equivalents for the period

4.1

Cash and cash equivalents at beginning of period

464

464

4.2

Net cash from / (used in) operating activities (item 1.9 above)

(1,234)

(1,234)

4.3

Net cash from / (used in) investing activities (item 2.6 above)

295

295

4.4

Net cash from / (used in) financing activities (item 3.10 above)

2,017

2,017

4.5

Effect of movement in exchange rates on cash held

20

20

4.6

Cash and cash equivalents at end of period

1,562

 

1,562

 

 

5.

Reconciliation of cash and cash equivalentsat the end of the quarter (as shown in the consolidated statement of cash flows) to the related items in the accounts

Current quarterUSD'000

Previous quarterUSD'000

5.1

Bank balances

3,405

3,015

5.2

Call deposits

32

33

5.3

Bank overdrafts

(1,875)

(1,267)

5.4

Other (provide details)

5.5

Cash and cash equivalents at end of quarter (should equal item 4.6 above)

1,562

1,781

 

6.

Payments to related parties of the entity and their associates

Current quarterUSD'000

6.1

Aggregate amount of payments to related parties and their associates included in item 1

6.2

Aggregate amount of payments to related parties and their associates included in item 2

Note: if any amounts are shown in items 6.1 or 6.2, your quarterly activity report must include a description of, and an explanation for, such payments.

 

7.

Financing facilitiesNote: the term "facility' includes all forms of financing arrangements available to the entity.

Add notes as necessary for an understanding of the sources of finance available to the entity.

Total facility amount at quarter endUSD'000

Amount drawn at quarter endUSD'000

7.1

Loan facilities

9,504

8,613

7.2

Credit standby arrangements

7.3

Other (please specify)

2,702

 

2,500

7.4

Total financing facilities

12,206

11,113

7.5

Unused financing facilities available at quarter end

1,093

7.6

Include in the box below a description of each facility above, including the lender, interest rate, maturity date and whether it is secured or unsecured. If any additional financing facilities have been entered into or are proposed to be entered into after quarter end, include a note providing details of those facilities as well.

USD0.9 million of the USD9.5 million provided by the Industrial Development Corporation of South Africa Limited ("IDC") to the company's subsidiary is still available for drawdown. The drawn amount plus interest is payable prior to 30 November 2020. Interest accrues at a real after tax rate of return of 16% on the advanced amount. Subsequent to the quarter end, an available amount of USD 0.9 million was drawn down at the same interest rate and is payable prior to 30 November 2020.

 

Of the USD2.7 million facility, USD1.2 million relates to the ABSA Facility that was secured during the 2019 financial year, from ABSA Bank Limited ("ABSA"). The facility is for short-term working capital requirements and potential expansion opportunities. The facility has a floating coupon at the South African Prime rate (currently 7% per annum) plus 1.0%, with the operating mine Uitkomst Colliery debtors ceded as security. The facility is subject to annual review. The short-term working facility was increased by an additional USD1.2 million in May 2020 to alleviate the financial challenges during the COVID-19 period and is secured by a general notarial bond over Uitkomst assets. This additional facility is temporary and is payable over twelve months commencing 1 July 2020 to 1 June 2021. During the period, the additional facility was reduced to $USD0.9 million due to the commencement of repayments. The same interest rate applies. $USD0.2 million of this facility was un-drawn at the end of the quarter.

 

The balance of the USD2.7 million relates to an equipment lease facility with ABSA that has been fully utilised. The lease facility has a five-year term at the South Africa prime interest rate (currently 7% per annum)

 

 

 

8.

Estimated cash available for future operating activities

USD'000

8.1

Net cash from / (used in) operating activities (item 1.9)

(1,234)

8.2

(Payments for exploration & evaluation classified as investing activities) (item 2.1(d))

(10)

8.3

Total relevant outgoings (item 8.1 + item 8.2)

(1,244)

8.4

Cash and cash equivalents at quarter end (item 4.6)

1,562

8.5

Unused finance facilities available at quarter end (item 7.5)

1,093

8.6

Total available funding (item 8.4 + item 8.5)

2,655

8.7

Estimated quarters of funding available (item 8.6 divided by item 8.3)

2

Note: if the entity has reported positive relevant outgoings (ie a net cash inflow) in item 8.3, answer item 8.7 as "N/A". Otherwise, a figure for the estimated quarters of funding available must be included in item 8.7.

8.8

If item 8.7 is less than 2 quarters, please provide answers to the following questions:

8.8.1 Does the entity expect that it will continue to have the current level of net operating cash flows for the time being and, if not, why not?

Answer: N/A

 

8.8.2 Has the entity taken any steps, or does it propose to take any steps, to raise further cash to fund its operations and, if so, what are those steps and how likely does it believe that they will be successful?

Answer: N/A

 

8.8.3 Does the entity expect to be able to continue its operations and to meet its business objectives and, if so, on what basis?

Answer: N/A

 

Note: where item 8.7 is less than 2 quarters, all of questions 8.8.1, 8.8.2 and 8.8.3 above must be answered.

 

Compliance statement

1 This statement has been prepared in accordance with accounting standards and policies which comply with Listing Rule 19.11A.

2 This statement gives a true and fair view of the matters disclosed.

 

 

Date: ...................................................................................

 

Disclosure Committee

Authorised by: ...................................................................................

(Name of body or officer authorising release - see note 4)

 

Notes

1. This quarterly cash flow report and the accompanying activity report provide a basis for informing the market about the entity's activities for the past quarter, how they have been financed and the effect this has had on its cash position. An entity that wishes to disclose additional information over and above the minimum required under the Listing Rules is encouraged to do so.

2. If this quarterly cash flow report has been prepared in accordance with Australian Accounting Standards, the definitions in, and provisions of, AASB 6: Exploration for and Evaluation of Mineral Resources and AASB 107: Statement of Cash Flows apply to this report. If this quarterly cash flow report has been prepared in accordance with other accounting standards agreed by ASX pursuant to Listing Rule 19.11A, the corresponding equivalent standards apply to this report.

3. Dividends received may be classified either as cash flows from operating activities or cash flows from investing activities, depending on the accounting policy of the entity.

4. If this report has been authorised for release to the market by your board of directors, you can insert here: "By the board". If it has been authorised for release to the market by a committee of your board of directors, you can insert here: "By the [name of board committee - eg Audit and Risk Committee]". If it has been authorised for release to the market by a disclosure committee, you can insert here: "By the Disclosure Committee".

5. If this report has been authorised for release to the market by your board of directors and you wish to hold yourself out as complying with recommendation 4.2 of the ASX Corporate Governance Council's Corporate Governance Principles and Recommendations, the board should have received a declaration from its CEO and CFO that, in their opinion, the financial records of the entity have been properly maintained, that this report complies with the appropriate accounting standards and gives a true and fair view of the cash flows of the entity, and that their opinion has been formed on the basis of a sound system of risk management and internal control which is operating effectively.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDPPGRWUUPUGMB
Date   Source Headline
27th Jul 20224:41 pmRNSSecond Price Monitoring Extn
27th Jul 20224:35 pmRNSPrice Monitoring Extension
15th Jul 202212:15 pmRNSResult of Extraordinary General Meeting
15th Jun 20224:25 pmRNSDespatch of Notice of General Meeting
6th Jun 202212:52 pmRNSStandby Loan Facility
17th May 20227:00 amRNSIssue of Shares Under Performance Rights Plan
29th Apr 20228:01 amRNSAppendix 5B
29th Apr 20228:00 amRNSActivities Report for the Quarter Ended 31 Mar 22
28th Apr 20227:00 amRNSChanges to the Board
14th Apr 20222:05 pmRNSSecond Price Monitoring Extn
14th Apr 20222:00 pmRNSPrice Monitoring Extension
14th Apr 202211:00 amRNSPrice Monitoring Extension
13th Apr 20224:40 pmRNSSecond Price Monitoring Extn
13th Apr 20224:35 pmRNSPrice Monitoring Extension
13th Apr 202212:54 pmRNSMakhado Bankable Feasibility Study Completed
11th Apr 20226:22 pmRNSREPLACEMENT:Results of EGM & Election of Directors
11th Apr 20224:57 pmRNSResults of EGM & Election of Directors
8th Apr 20222:30 pmRNSResignation of Executive Director
6th Apr 20224:18 pmRNSIssue of First Tranche Shares and TVR
17th Mar 20224:41 pmRNSSecond Price Monitoring Extn
17th Mar 20224:36 pmRNSPrice Monitoring Extension
14th Mar 20227:00 amRNSInterim Financial Report
14th Mar 20227:00 amRNSHalf-year Results
11th Mar 20227:00 amRNSResignation of Non-Executive Chairman
8th Mar 20222:23 pmRNSHolding(s) in Company
4th Mar 20229:59 amRNSDespatch Notice of Extraordinary General Meeting
1st Mar 20229:10 amRNSCompany Update
22nd Feb 20223:57 pmRNSHolding(s) in Company
14th Feb 20227:00 amRNSNotice Received Under Section 249D
1st Feb 20227:00 amRNSCapital Raising US$5.6 million
31st Jan 20227:24 amRNSActivities Report for the Quarter Ended 31 Dec 21
31st Jan 20227:23 amRNSAppendix 5B
28th Jan 20224:08 pmRNSIDC Loan Update
17th Jan 20223:43 pmRNSGrant of Performance Rights to Directors
11th Jan 20227:00 amRNSMakhado Project Update
14th Dec 20212:38 pmRNSBoard Changes
14th Dec 20212:35 pmRNSResult of Annual General Meeting
16th Nov 20217:00 amRNSDespatch of Notice of AGM
29th Oct 20212:45 pmRNSDespatch of Annual Report
29th Oct 202110:26 amRNSAppendix 5B
29th Oct 202110:25 amRNSReport for the Quarter Ended 30 September 2021
22nd Oct 202111:15 amRNSHolding(s) in Company
20th Oct 202110:30 amRNSHolding(s) in Company
19th Oct 20212:26 pmRNSAnnual General Meeting Details
8th Oct 20217:30 amRNSHolding(s) in Company
30th Sep 20216:01 pmRNSAnnual Financial Report
30th Sep 20216:00 pmRNSResults for the Full Year Ended 30 June 2021
7th Sep 20218:29 amRNSHolding(s) in Company
30th Jul 20218:04 amRNSReport for the Quarter Ended 30 June 2021
30th Jul 20218:01 amRNSAppendix 5B

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.